{"id":20257411,"updated":"2025-11-14T02:58:37Z","additionalIndexing":"2841;08","affairType":{"abbreviation":"Fra.","id":14,"name":"Fragestunde. Frage"},"author":{"councillor":{"code":10832,"gender":"m","id":10832,"name":"Knutti Thomas","officialDenomination":"Knutti"},"faction":{"abbreviation":"Fraktion V","code":"V","id":4,"name":"Fraktion der Schweizerischen Volkspartei"},"type":"author"},"deposit":{"council":{"abbreviation":"NR","id":1,"name":"Nationalrat","type":"N"},"date":"2025-06-04T00:00:00Z","legislativePeriod":52,"session":"5209"},"descriptors":[],"drafts":[{"consultation":{"resolutions":[{"category":{"id":3,"name":"Normal"},"council":{"abbreviation":"NR","id":1,"name":"Nationalrat","type":"N"},"date":"2025-06-10T00:00:00Z","text":"Mündliche Beantwortung der Frage","type":82}]},"federalCouncilProposal":{},"index":0,"links":[],"preConsultations":[],"references":[],"relatedDepartments":[{"abbreviation":"EDI","id":4,"name":"Departement des Innern","leading":true}],"states":[{"date":"\/Date(1748988000000+0200)\/","id":202,"name":"Eingereicht"},{"date":"\/Date(1749506400000+0200)\/","id":229,"name":"Erledigt"}],"texts":[]}],"language":"de","priorityCouncils":[{"abbreviation":"NR","id":1,"name":"Nationalrat","type":"N","priority":1}],"relatedAffairs":[],"roles":[{"councillor":{"code":10832,"gender":"m","id":10832,"name":"Knutti Thomas","officialDenomination":"Knutti"},"faction":{"abbreviation":"Fraktion V","code":"V","id":4,"name":"Fraktion der Schweizerischen Volkspartei"},"type":"author"}],"shortId":"25.7411","state":{"id":229,"name":"Erledigt","doneKey":"0","newKey":0},"texts":[{"type":{"id":5,"name":"Eingereichter Text"},"value":"<p>Am 19. Juli 2025 endet die Frist für das Opting out zu den revidierten IGV. Der Bundesrat hat bis dato keine Anstalten getroffen, den Widerspruch zu erklären.&nbsp;<br>Warum wartet der Bundesrat nicht mit der Annahme der angepassten IGV, solange bis eine umfangreiche Analyse von Nebenwirkungen der eingesetzten mRNA-Präparaten vorliegt?<\/p>"},{"type":{"id":1,"name":"Titel des Geschäftes"},"value":"Internationale Gesundheitsvorschriften (IGV): Fehlende Analyse vor weiteren Schritten"}],"title":"Internationale Gesundheitsvorschriften (IGV): Fehlende Analyse vor weiteren Schritten"}